Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16965225
Conclusion of this study
UDCA is an effective drug in the treatment of ICP, and combined with SAMe, has probably a synergistic effect on biochemical parameters. This mode of treatment seems more effective but the effect of the successful treatment on the fetus is unclear. Therefore, the ante- and intrapartum monitoring of the fetus should be part of the management of severe forms of ICP. The project is supported by IGA MZ CR (No. NH/7376-3).
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study